In univariable Cox proportional hazards analysis, GLP-1RA use was associated with a lower hazard of the primary outcome compared with DPP-4i therapy (HR 0.75, 95% CI 0.600.94
About this article Cite this article Atwal, P., Medina, C., Burrage, L
This exclusive program offers you regular treatments to help you achieve your health goals
Heartburn/Acid Reflux: Less common, but possible, potentially due to slowed digestion
The data from various countries seemed to show people using GLP-1s were diagnosed less often with cognitive dysfunction and Alzheimers
In the Phase 2 trial, 100% of participants on 8mg or 12mg achieved at least 5% weight loss (the threshold for health benefits)